These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study]. Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670 [TBL] [Abstract][Full Text] [Related]
3. The clinical significance of antinuclear antibodies in connective tissue disease. Pahor A; Krajnc I; Gorenjak M; Holc I Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626 [TBL] [Abstract][Full Text] [Related]
4. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764 [TBL] [Abstract][Full Text] [Related]
5. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods]. Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146 [TBL] [Abstract][Full Text] [Related]
6. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features]. Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881 [TBL] [Abstract][Full Text] [Related]
7. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases. Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549 [TBL] [Abstract][Full Text] [Related]
8. Clinical diagnostic performance of different methods for the detection of antibodies to extractable nuclear antigens in connective tissue diseases: a cohort study. Lora PS; Laurino CC; Becker BS; Monticielo OA; Brenol JC; Xavier RM Clin Lab; 2011; 57(7-8):625-9. PubMed ID: 21888028 [TBL] [Abstract][Full Text] [Related]
9. From ANA to ENA: how to proceed? Damoiseaux JG; Tervaert JW Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods. Desplat-Jego S; Bardin N; Larida B; Sanmarco M Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313 [TBL] [Abstract][Full Text] [Related]
12. Detection of autoantibodies to nuclear antigens by EIA and IF techniques. Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708 [TBL] [Abstract][Full Text] [Related]
13. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of quantitative measurement of various antinuclear antibodies by enzyme immunoassay]. Miyawaki S Rinsho Byori; 1994 May; 42(5):467-75. PubMed ID: 8022075 [TBL] [Abstract][Full Text] [Related]
15. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Copple SS; Martins TB; Masterson C; Joly E; Hill HR Ann N Y Acad Sci; 2007 Aug; 1109():464-72. PubMed ID: 17785335 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies]. Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases. Vercammen M; Meirlaen P; Sennesael J; Velkeniers B; T'Kint S; Verbruggen L; Haentjens P; Broodtaerts L; Demanet C; De Waele M Clin Chem Lab Med; 2007; 45(4):505-12. PubMed ID: 17439329 [TBL] [Abstract][Full Text] [Related]
18. [Antibodies against soluble nuclear antigens ENA, RNP and Sm: comparison of different detection methods in collagen diseases (author's transl)]. Rivero S; Sánchez G Rev Med Chil; 1981 Aug; 109(8):711-6. PubMed ID: 6177024 [No Abstract] [Full Text] [Related]
19. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Lazzerini PE; Acampa M; Guideri F; Capecchi PL; Campanella V; Morozzi G; Galeazzi M; Marcolongo R; Laghi-Pasini F Arthritis Rheum; 2004 Apr; 50(4):1248-52. PubMed ID: 15077308 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. Faria AC; Barcellos KS; Andrade LE J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]